Bullish Case: The Marvell $115B all-stock deal (4.5x MRVL ratio, ~$1,132 implied at announcement) anchors LITE's value; MRVL has since slid ~12%+ in the semis de-grossing, making LITE at $680 a steep ~40% spread to the fixed-ratio peg. Board approvals are unanimous, Nvidia backed both firms, and capacity is sold out through 2029—if MRVL stabilizes, convergence is powerful.

Bearish Case: LITE is now a leveraged MRVL proxy: all-stock, fixed-ratio, closing H1 2028 means ~16 months of MRVL beta, index-forced selling, and de-grossing risk. Semis broke their 200-day MA, hedge funds are underweight AI, and Helium's backwardated term structure (144%+ near IV vs ~60% at 2m) plus 126% put-heavy flow signal continued downside pressure toward the $620–650 density peak.

Potential Outcomes:

1. 35% — Convergence drift: MRVL stabilizes; LITE tracks 4.5×MRVL + modest residual spread; range $640–$780 (falsified if ratio-peg loosens).
2. 25% — AI/macro selloff deepens: SOX stays below 200d MA; MRVL falls further; LITE to $560–$630 (falsified by semis reclaiming 200d).
3. 20% — Deal renegotiation or break: shareholder revolt/dilution fears (Barron's 'mistake' narrative); LITE re-rates on standalone $900+ capacity story or drops to $550 (falsified by formal ratification).
4. 15% — Semis rebound: SPY calms, MRVL bounces; LITE $780–$880 (falsified by continued de-grossing).
5. 5% — Competing bid/coherent counter: a topping bid >$1,200; tail upside.

November 05, 2026